Pfizer Announces Positive Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Infants Pharmaceutical Investing
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Professional Holding Corp. , Global Blood Therapeutics, Inc. , CyberOptics Corporation , EVO Payments, Inc. Â Â Â Pharmaceutical Investing
New Study Shows Abbott's Blood Test for Concussion Could Predict Outcomes from Brain Injury and Inform Treatment Interventions Pharmaceutical Investing
Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit Pharmaceutical Investing
BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights Pharmaceutical Investing
Lobe Sciences Enters into an Exclusive Agreement With iNGENu to Conduct Clinical Trials in Australia Pharmaceutical Investing
Salix Supports CMS Announcement of First ICD-10 Code for Hepatic Encephalopathy Pharmaceutical Investing
Bristol Myers Squibb and 2seventy bio Announce Topline Results from KarMMa-3 Trial Showing Abecma Significantly Improves Progression-Free Survival Versus Standard Regimens in Relapsed and Refractory Multiple Myeloma Pharmaceutical Investing
Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference Pharmaceutical Investing
Gilead Sciences and a Coalition of LGBTQ+ and Human Rights-Focused Organizations Mobilize to Address Monkeypox Public Health Emergency Pharmaceutical Investing
